HomeAI · summaries
Storia in 4 fonti
Ozempic changed obesity treatment, but experts say the real revolution is next
The obesity treatment landscape is changing fast, with GLP-1 drugs opening the door to more effective care than ever before. Experts now envision a future where medications, minimally invasive procedures, surgery, and precision medicine work together to deliver better long-term results.
Confronto fonti
4 prospettive sulla stessa storiaTimeline cronologica
- ·
gizmodo.com
Can Ozempic Treat Alcoholism? Here's What You Should Know
A recent trial is the latest to suggest that GLP-1s aren't just for treating diabetes and obesity.
- ·
iol.co.za
The good, bad and ugly of GLP-1 weight-loss drugs: Ozempic scams, celebrity hype and nasty side effects
From dramatic weight loss to dangerous side effects and fake Ozempic scams, here’s the truth about the GLP-1 craze gripping South Africa and Hollywood.
- ·
sciencedaily.com
Ozempic and similar weight-loss drugs linked to 30% lower breast cancer risk
A large study found that women taking GLP-1 drugs, the medication class behind Ozempic, Wegovy, Mounjaro, and Zepbound, were about 30% less likely to develop breast cancer.…
- ·
Ozempic changed obesity treatment, but experts say the real revolution is next
The obesity treatment landscape is changing fast, with GLP-1 drugs opening the door to more effective care than ever before. Experts now envision a future where medications,…
- ·
People taking GLP-1 weight loss drugs like Ozempic started moving less
People taking popular weight-loss drugs such as Ozempic, Wegovy, Mounjaro, and Zepbound may be losing pounds, but they could also be moving less. Researchers analyzing Fitbit data…
- ·
Ozempic and Wegovy linked to surprising drop in violent behavior
A Rutgers study suggests GLP-1 drugs such as Ozempic and Wegovy may weaken the link between impulsive tendencies and violent behavior. The surprising finding hints that these…
- ·
independent.co.uk
The tortilla label change that weight-loss drug companies are cashing in on
While a ‘GLP-1 friendly’ label may seem arbitrary, some medical experts say it may make people pay closer attention to what they’re eating